2025-11-04 18:57
Neola Medical Q3 Report 2025 – Progressing toward completion of Swedish clinical pilot study and strengthening leadership team

2025-11-04 18:53
Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola®

2025-10-16 08:00
Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola®

2025-10-01 07:00
Neola Medical’s CEO highlights recent progress in autumn 2025 investor letter

2025-09-25 07:20
Neola Medical strengthens leadership team with appointment of Clinical Director

2025-09-10 07:00
Neola Medical granted European patent enabling lung monitoring beyond preterm born babies

2025-08-25 07:55
Neola Medical Q2 Report 2025 – First U.S. Clinical Study Site Agreement Signed, Key Step in Regulatory Path to Market Authorization

2025-08-18 07:00
Neola Medical invites to presentation of the Q2-report 2025

2025-06-16 11:00
Neola Medical’s CEO shares clinical progress and recent milestones in summer 2025 investor letter

2025-06-10 07:00
Neola Medical Signs Agreement with Leading U.S. Hospital for Pivotal Clinical Study on Preterm Born Babies Following IRB Approval

Next

Subscribe